Target intelligence / Profile preview

Ribosomal protein L21 pseudogene 113 (RPL21P113)

Target: RPL21P113
Molecular classification: Other

Overview

Ribosomal protein L21 pseudogene 113 (RPL21P113) is a human pseudogene related to the ribosomal protein L21 gene. It does not encode a functional protein product and is not involved in canonical biological processes or disease mechanisms. Pseudogenes such as RPL21P113 result from gene duplication or retrotransposition events and are generally considered non-functional genomic elements. No known biological function, disease association, or drug interaction is attributed to this pseudogene.

Other names: RPL21_51_1437

Beyond the preview

Go deeper on Ribosomal protein L21 pseudogene 113 (RPL21P113).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L21 pseudogene 113 (RPL21P113).

Explore the full profile